HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[CB1 receptor inhibition and glucose metabolism: role of rimonabant in type 2 diabetes].

Abstract
Endocannabinoid system is overactivated in individuals with abdominal obesity. CBI receptors, first individualized in the brain, are also expressed in the adipocyte, the skeletal muscle, the liver, the gut, and the pancreas. Their blockade improves glucose tolerance and lipid profile, thanks increased insulin sensitivity and adiponectin levels. Rimonabant, a selective antagonist of CBI receptors, improves glucose control in patients with type 2 diabetes, treated with diet alone, metformin, sulfonylurea or insulin, while it also reduces body weight and other risk factors. Ongoing studies aim at further demonstrating the potential of rimonabant in the management of type 2 diabetes, in the prevention of type 2 diabetes and in the protection against cardiovascular complications in (diabetic) patients with abdominal obesity.
AuthorsAndré J Scheen, Nicolas Paquot, Luc F Van Gaal
JournalRevue medicale suisse (Rev Med Suisse) Vol. 4 Issue 168 Pg. 1812-7 (Aug 27 2008) ISSN: 1660-9379 [Print] Switzerland
Vernacular TitleInhibition des récepteurs CB1 et métabolisme du glucose: rimonabant dans le diabète de type 2.
PMID18814765 (Publication Type: Journal Article, Review)
Chemical References
  • Blood Glucose
  • Hypoglycemic Agents
  • Piperidines
  • Pyrazoles
  • Receptor, Cannabinoid, CB1
  • Rimonabant
Topics
  • Blood Glucose (metabolism)
  • Diabetes Mellitus, Type 2 (drug therapy, metabolism)
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Piperidines (therapeutic use)
  • Pyrazoles (therapeutic use)
  • Receptor, Cannabinoid, CB1 (antagonists & inhibitors, metabolism)
  • Rimonabant

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: